Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Translate Bio

Request full access

Developing mRNA medicines to restore protein function

Cambridge, United StatesFounded 2011Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2018

Translate Bio in the Cambridge ecosystem

Live from Dealroom

The Translate Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Omega Funds
  • SR One
  • Atlas Venture
  • M Ventures
  • Partners Innovation Fund

Series B and later6 investors entered at this stage

  • Rock Springs Capital
  • Massachusetts Institute of Technology
  • Brookside Capital
  • Pfizer
  • Transformation Capital
  • Monsanto Growth Ventures
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Patents

Estimated portfolio value
$336M

153 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Translate Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.